p2) and TCGA databases, we found that TFRC had a higher expression in multiple cancers, including LGG, glioblastoma multiforme (GBM), invasive breast carcinoma no special type (NST), kidney chromophobe cancer (KICH), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), acute myeloid leukemia (AML), and liver hepatocellular carcinoma (LIHC), than in the corresponding normal tissues (Figure 1A and Supplementary Figure 2). The gene discussed is TFRC; the disease is glioblastoma.